Aortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year...

Area of Science:

• Cardiology
• Pulmonology
• Vascular Biology

Background:

• Cardiovascular disease is a leading cause of death in COPD patients.
• Arterial stiffness, a predictor of cardiovascular risk, is elevated in COPD.
• Prospective data on arterial stiffness development in COPD is limited.

Purpose of the Study:

• To investigate factors associated with aortic pulse wave velocity (aPWV) at baseline in COPD patients.
• To track the progression of aPWV over two years in COPD patients and healthy comparators.
• To contribute to the Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE) study.

Main Methods:

• A longitudinal study involving 520 COPD patients and 150 controls.
• Baseline and two-year assessments included body composition, blood pressure, aPWV, cardiac output, inflammatory biomarkers, and exercise capacity.
• Mortality data and causes were recorded over the follow-up period.

Main Results:

• COPD patients exhibited significantly higher baseline aPWV (9.8 m/s) compared to controls (8.7 m/s) after adjustments.
• Over two years, aPWV increased similarly in both groups by approximately 0.45 m/s, irrespective of blood pressure changes.
• Twenty-nine deaths (6%) occurred in COPD patients, primarily from respiratory causes.

Conclusions:

• This study confirms higher arterial stiffness (aPWV) in COPD patients compared to controls, even after accounting for confounding factors.
• Arterial stiffness progression over two years was comparable between COPD patients and healthy individuals.
• The findings highlight the importance of monitoring cardiovascular risk in COPD management.